Deiana Inc SRL

Deiana Inc reported total assets of 93,085 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).

Company number (CBE) 0761.638.357 · VAT BE0761638357
7000 Mons
active in Research and experimental development on other natural sciences and engineering (NACE 72109)
operating since 15 Jan 2021 (≈ 5 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Deiana Inc shows with a free account.

See the score
Profile
SRL since 2021
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result−11,576 €
Equity−53,052 €
Cash28,224 €
EBITDA4,667 €
Total assets93,085 €
Solvency-57.0%
The line marks its sector median: 57.9% (333 companies).

Change 2022 → 2025: Total assets -37 %

Accounts of the company itself (not consolidated).

The full file covers 5 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Deiana Inc's annual accounts

20252024202320222021
Net result−11,576 €
Equity−53,052 €
Cash28,224 €
EBITDA4,667 €
Total assets93,085 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 30 Sep 2026
  • Year ended 31 Dec 2024filed on 18 Aug 2025
  • Year ended 31 Dec 2023filed on 05 Jun 2025
  • Year ended 31 Dec 2022filed on 31 Oct 2023
  • Year ended 31 Dec 2021filed on 30 Sep 2022

Deiana Inc's financial analysis

Management and control of Deiana Inc

1 active director(s) in the register.

Deiana Inc's shareholders and holdings →

Deiana Inc's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0761.638.357
VAT number
BE0761638357
Peppol
Registered · 0208:0761638357 · as of 10 Nov 2026
Legal form
SRL
Incorporated
15 Jan 2021
Registered office
7000 Mons
Latest accounts
2025 · filed on 30 Sep 2026
Activity
Research and experimental development on other natural sciences and engineering (NACE 72109)

Deiana Inc (SRL) has been based in Mons since 2021, active in: research and experimental development on other natural sciences and engineering. For 2025, it reports a net loss of 11,576 € and equity of −53,052 €; its revenue is not published. Its solvency stands at -57.0%, below the median of its sector (57.9%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Deiana Inc

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Deiana Inc

What is the revenue of Deiana Inc?

Deiana Inc files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Deiana Inc?

In Belgium, the VAT number is the company number prefixed with BE: BE0761638357 for Deiana Inc, if the company is VAT-registered. Its company number (CBE) is 0761.638.357.

Where is the registered office of Deiana Inc?

According to the CBE register, the registered office of Deiana Inc is in 7000 Mons.

What is the equity of Deiana Inc?

At the close of the 2025 financial year, the equity of Deiana Inc amounts to -53,052 €, a solvency of -57.0% of total assets.

Who manages Deiana Inc?

The register lists 1 active mandates at Deiana Inc. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Deiana Inc

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 08 Oct 2026

No credit card, no commitment.

What each plan unlocks →